From March 2 to 8, the official website of the China Securities Regulatory Commission (CSRC) revealed that six newly added companies have successfully secured approvals for overseas offerings and listings. These companies are Shenzhen Ldrobot, Puyuan Precision, Beijing DeepMatrix Intelligence, Shenzhen Medcaptain Biomedical, Victory Giant Technology (Huizhou), and Cofoe Medical. Each of these firms intends to issue ordinary shares as part of their overseas listing strategy, with plans to go public on the Hong Kong Stock Exchange. Furthermore, certain shareholders of Ldrobot, DeepMatrix Intelligence, and Medcaptain Biomedical have expressed their intention to convert their unlisted domestic shares into H shares, aligning with the broader trend of internationalizing their capital structures.
